Phase 3 Study to Compare a Rapid Immunization Regime With the Standard Regime of IC51 as Vaccine for Japanese Encephalitis.

Trial Profile

Phase 3 Study to Compare a Rapid Immunization Regime With the Standard Regime of IC51 as Vaccine for Japanese Encephalitis.

Completed
Phase of Trial: Phase III

Latest Information Update: 15 May 2014

At a glance

  • Drugs IC 51 (Primary)
  • Indications Japanese encephalitis
  • Focus Pharmacodynamics; Registrational
  • Sponsors Intercell
  • Most Recent Events

    • 09 Jun 2010 Results of the long-term follow-up study reported in Vaccine.
    • 01 Mar 2009 Results published in Vaccine 27: 2188-2193, No. 15, 26 Mar 2009
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top